Growth • Hypera Pharma
HYPE3
Hypera Pharma SA is a company that manufactures generic and specialty drugs. It focuses on the main pharmaceutical segments of the Brazilian market, along with a presence in over-the-counter and generic drugs. Hypera Pharma also has a share of generic drugs and prescription products. It also has a wide sales and distribution structure.
17,7%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
32,4%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
2,9%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
2,9%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
2,8%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
25,3%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!